Wayshine Biopharm attended AACR 2022  in New Orleans, and associated with Mayo Clinic to present the poster with impressive preclinical data of the independently research and development radiosensitizer small molecule drug WSD0628, WSD0628 has been highlighted at the meeting final vision for the future !